1
|
Rodríguez-Sanz A, Peña-Llamas E, Alonso-Cánovas A, Alonso-Frech FA, Borrue-Fernández C, Catalán MJ, Fanjul-Arbós S, García-Cobos E, García-Ramos R, García Ruiz-Espiga P, Herreros-Rodríguez J, Kurtis-Urra M, López-Lozano JJ, López-Manzanares L, Martínez-Castrillo JC, Martínez-Fernández R, Mata M, Pérez-Sánchez JR, Posada IJ, Rojo A, Romero-Muñoz JP, Ruiz-Huete C, Sánchez-Alonso MP, Vivancos-Matellano F, En Representación Del Grupo de Trastornos Del Movimiento de la Asociación Madrileña de Neurología ERDGDTDMDLAMDN. [Clinical experience in the treatment of motor fluctuations in Parkinson's disease. Delphi consensus of a group of experts in movement disorders]. Rev Neurol 2020; 71:407-420. [PMID: 33205387 DOI: 10.33588/rn.7111.2020088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
INTRODUCTION Motor fluctuations are one of the most common complications of Parkinson's disease and their treatment is still a complex matter. Therefore, from the Neurology Movement Disorders Group we present our clinical experience in the treatment of these complications, with the intention of it being useful in decision-making in daily clinical practice. DEVELOPMENT Nineteen questions were developed based on a literature review and an open survey answered by members of this group. These issues were discussed in two phases, using the Delphi methodology. Considering the results of the survey, levodopa dose adjustment and dopamine agonists are the option with the best efficacy/tolerability ratio in the treatment of motor fluctuations. Rotigotine is useful in the motor fluctuations associated with gastroparesis, and intermittent subcutaneous apomorphine has positive effects in patients with unpredictable off periods. The most relevant adverse effect associated with dopamine agonists is impulse control disorder. Catechol-O-methyltransferase inhibitors are useful in the initial stages of motor fluctuations, especially in wearing off. Monoamine oxidase inhibitors are generally drugs that are well-tolerated and useful in motor fluctuations. If these measures are not effective, second-line treatments should be indicated on a case-by-case basis. CONCLUSION The clinical profile of patients with Parkinson's disease is paramount in deciding the most appropriate therapy for the treatment of motor fluctuations.
Collapse
Affiliation(s)
| | | | | | | | | | - M J Catalán
- Hospital Universitario Clínico San Carlos, Madrid, España
| | | | | | - R García-Ramos
- Hospital Universitario Clínico San Carlos, Madrid, España
| | | | | | | | - J J López-Lozano
- Hospital Universitario Puerta de Hierro-Majadahonda, 28035 Majadahonda, España
| | | | | | | | - M Mata
- Hospital Universitario Infanta Sofía, Madrid, España
| | | | - I J Posada
- Hospital Universitario 12 de Octubre, Madrid, España
| | - A Rojo
- Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, España
| | | | - C Ruiz-Huete
- Hospital Nuestra Señora del Rosario, Madrid, España
| | - M P Sánchez-Alonso
- Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, España
| | | | | |
Collapse
|